Skip to content

Quantification of Autonomic Nervous Activity During Hemodialysis

Quantification of Autonomic Nervous Activity by Heart Rate Variability and Approximate Entropy in High Ultrafiltration Rate During Hemodialysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02754986
Enrollment
35
Registered
2016-04-28
Start date
2015-03-31
Completion date
Unknown
Last updated
2016-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease on Hemodialysis

Keywords

heart rate variability

Brief summary

This study assesses autonomic nervous system function by power spectral analysis of RR interval dynamics in ultrafiltration subjects without blood pressure variation.

Detailed description

Variations over time in autonomic nervous activity due to differences in ultrafiltration rate will be evaluated by measuring heart rate variability in hemodialysis patients without blood pressure variations during HD session. The subjects will be divided into 3 groups, those with UFR \< 10 ml/hr/kg; ≥10 ml/hr/kg but ≤ 15 ml/hr/kg; and \>15 ml/hr/kg, and Holter ECG are recorded continuously during HD session using frequency analysis of RR intervals.

Interventions

OTHERAnalysis of the holter electrocardiogram

Sponsors

University of Hyogo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with stable undergoing hemodialysis without hanging in blood pressure during hemodialysis.

Exclusion criteria

* Patients with chronic atrial fibrillation * Patients with frequent ventricular premature beats * Patients with a permanent pacemaker * Patients with taking antihypertensive drugs * Patients with medical treatment due to changes in blood pressure

Design outcomes

Primary

MeasureTime frameDescription
The outcome measures was low frequency power (LF, ms2) to high frequency power (HF, ms2) ratio (LF/HF ratio) of heart rate variability. The three subject groups with difference ultrafiltration were compared by LF/HF ratio during hemodialysis session.4 hoursVariations over time in autonomic nervous activity due to differences in ultrafiltration rate will be evaluated by measuring heart rate variability.

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026